Latest Share Chat

ValiRx Share News (VAL)

ValiRx Information

Buy VAL Shares
Add VAL to Watchlist
Add VAL to Alert

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.90

Bid: 1.80

Ask: 2.00

Change: 0.00 (0.00%)

Spread: 0.20 (11.111%)

Open: 1.90

High: 1.90

Low: 1.90

Prev. Close: 1.90

Last checked at -

ValiRx Confirms JV Talks For Non-Core Intellectual Property

Wed, 29th Apr 2020 18:19

(Alliance News) - Biotechnology company ValiRx PLC on Wednesday confirmed joint venture talks for its non-core intellectual property, GeneICE, TRAC and BioFit.

Shares in the company closed 25% higher at 7.49 pence each in London.

"The company confirms that it is in talks with a third-party in relation to a joint venture. However, there is no certainty the talks will conclude in a successful manner, nor that in the event that the Joint Venture is agreed, that the terms will be favourable to the company," ValiRx said in a statement.

By Tapan Panchal; tapanpanchal@alliancenews.com

More News

10 Nov 2020 17:40

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

23 Sep 2020 19:09

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

7 Sep 2020 11:55

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

29 May 2020 15:02

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

29 May 2020 12:59

ValiRx offloads non-core IP to DDTech

(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.

Latest Share Chat

ValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ValiRx Confirms JV Talks For Non-Core Intellectual Property

Login to your account

Quickpicks are a member only feature

Login to your account